- HLA Group reported a net income of 1.58 billion yuan for the first half of the year 2025.
- The company’s revenue for this period stood at 11.57 billion yuan.
- Analysts are positive on HLA Group, with 20 buy recommendations and no hold or sell recommendations.
A look at HLA CORP., Ltd. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, HLA CORP., Ltd. shows a promising long-term outlook. With strong scores of 4 in Value, Growth, Resilience, and a top score of 5 in Dividend, the company appears well-positioned for sustained performance. HLA CORP., Ltd. is highly regarded for its solid financial value, consistent growth prospects, and resilience in the face of market challenges, making it an attractive option for investors seeking stable returns. Although the Momentum score of 2 indicates some room for improvement in short-term performance, the overall outlook for HLA CORP., Ltd. remains positive.
HLA CORP., Ltd. is a leading manufacturer and distributor in the apparel and textile industry. Known for producing a wide range of products including woolen fabrics, yarns, and textile raw materials, the company also offers dyeing and processing services. Heilan Home, the global distributor of HLA CORP., Ltd. products, ensures a wide reach for their high-quality offerings. With impressive Smartkarma Smart Scores across key factors such as Value, Dividend, Growth, and Resilience, HLA CORP., Ltd. stands out as a strong contender in the market for long-term investment opportunities.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
